Conditions: Diabetic Foot Infections
Keywords: Diabetic Foot Infections, DFI, Nemonoxacin
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 40
Healthy volunteers: no

Brief summary:
Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections

Detailed description:
This study will assess the safety and efficacy of TG-873870 (Nemonoxacin) in patients with Diabetic Foot Infections. Pharmacokinetic (PK) and pharmacodynamic (PD) assessment will be conducted in a subgroup of eight consenting patients.

Arms:
arm 1: Nemonoxacin 750 mg,oral administration, single-arm, once daily 7±1 and 14±1 days.

Interventions: intervention 1: TG-873870 (Nemonoxacin)
Intervention descriptions: intervention 1: 750 mg

Protocol document: